Skip to main content
. 2023 Dec 1;4(6):1136–1144. doi: 10.37349/etat.2023.00187

Figure 3.

Figure 3

Forest plots showing the association of systemic therapy in metastatic ALK-positive NSCLC. (A) OS; (B) PFS; (C) CNS PFS; (D) grade ≥ 3 AEs